TY - CHAP M1 - Book, Section TI - Treatment of Infections III: Antifungal and Antiparasitic Drugs A1 - Ciccone, Charles D. A1 - Bednarek, Melissa L. A1 - Miller, Kenneth L. PY - 2022 T2 - Pharmacology in Rehabilitation, 5e AB - Humans are susceptible to infection by a number of parasitic species of fungi, protozoa, and helminths (worms). Although some types of parasitic infections are limited or unknown in developed nations such as the United States, parasitic infections generally represent the most common form of disease worldwide. These infections are especially prevalent in tropical and subtropical environments and in impoverished areas of the world where sanitation and hygiene are inadequate. In addition, the incidence of serious fungal and other parasitic infections has been increasing in industrialized nations because of the increased susceptibility of immunocompromised patients to these infections, such as patients with HIV or those receiving immunosuppressant drugs after organ transplantation.1-3 Hence, the effective pharmacological treatment of these infections remains an important topic in the global management of disease. SN - PB - F. A. Davis Company CY - New York, NY Y2 - 2024/03/29 UR - fadavisat.mhmedical.com/content.aspx?aid=1188531110 ER -